ATE352629T1 - Kvlqt1 - ein gen des long-qt-syndroms, welches für kvlqt1 kodiert und welches sich mit mink zusammensetzt, um iks-kaliumkanäle des herzens zu bilden - Google Patents

Kvlqt1 - ein gen des long-qt-syndroms, welches für kvlqt1 kodiert und welches sich mit mink zusammensetzt, um iks-kaliumkanäle des herzens zu bilden

Info

Publication number
ATE352629T1
ATE352629T1 AT96945935T AT96945935T ATE352629T1 AT E352629 T1 ATE352629 T1 AT E352629T1 AT 96945935 T AT96945935 T AT 96945935T AT 96945935 T AT96945935 T AT 96945935T AT E352629 T1 ATE352629 T1 AT E352629T1
Authority
AT
Austria
Prior art keywords
kvlqt1
long
syndrome
gene
acid sequence
Prior art date
Application number
AT96945935T
Other languages
English (en)
Inventor
Mark T Keating
Michael C Sanguinetti
Mark E Curran
Original Assignee
Univ Utah Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26691739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE352629(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Utah Res Found filed Critical Univ Utah Res Found
Application granted granted Critical
Publication of ATE352629T1 publication Critical patent/ATE352629T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
AT96945935T 1995-12-22 1996-12-20 Kvlqt1 - ein gen des long-qt-syndroms, welches für kvlqt1 kodiert und welches sich mit mink zusammensetzt, um iks-kaliumkanäle des herzens zu bilden ATE352629T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1901495P 1995-12-22 1995-12-22
US73938396A 1996-10-29 1996-10-29

Publications (1)

Publication Number Publication Date
ATE352629T1 true ATE352629T1 (de) 2007-02-15

Family

ID=26691739

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96945935T ATE352629T1 (de) 1995-12-22 1996-12-20 Kvlqt1 - ein gen des long-qt-syndroms, welches für kvlqt1 kodiert und welches sich mit mink zusammensetzt, um iks-kaliumkanäle des herzens zu bilden
AT96946233T ATE427993T1 (de) 1995-12-22 1996-12-20 EIN GEN DES ßLANGEN QT SYNDROMSß (LONG QT SYNDROM), WELCHES KVLQT1 KODIERT UND SEINE WECHSELWIRKUNG MIT MINK

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT96946233T ATE427993T1 (de) 1995-12-22 1996-12-20 EIN GEN DES ßLANGEN QT SYNDROMSß (LONG QT SYNDROM), WELCHES KVLQT1 KODIERT UND SEINE WECHSELWIRKUNG MIT MINK

Country Status (11)

Country Link
EP (3) EP0876491B1 (de)
JP (2) JP2001519646A (de)
AT (2) ATE352629T1 (de)
AU (2) AU714041B2 (de)
CA (1) CA2240737C (de)
DE (2) DE69637895D1 (de)
DK (1) DK0876491T3 (de)
ES (1) ES2325820T3 (de)
NZ (2) NZ330744A (de)
PT (1) PT876491E (de)
WO (2) WO1997023632A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274332B1 (en) * 1995-12-22 2001-08-14 Univ. Of Utah Research Foundation Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
US6277978B1 (en) * 1995-12-22 2001-08-21 University Of Utah Research Foundation KVLQT1—a long QT syndrome gene
JP4520634B2 (ja) 1997-10-24 2010-08-11 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション 良性の家族性新生児痙攣（ｂｆｎｃ）および他の癲癇において突然変異されたｋｃｎｑ２およびｋｃｎｑ３−カリウムチャンネル遺伝子
GB9726339D0 (en) * 1997-12-13 1998-02-11 Zeneca Ltd Human-derived tissue-specific potassium channel
EP1056765A4 (de) * 1998-02-25 2003-07-30 Icagen Inc Menschliche kaliumkanal-gene
US6071720A (en) 1998-04-29 2000-06-06 Incyte Pharmaceuticals, Inc. Delayed rectifier potassium channel subunit
US6794161B1 (en) 1999-01-26 2004-09-21 Neurosearch A/S Potassium channels and genes encoding these potassium channels
DK1147134T3 (da) * 1999-01-26 2007-02-05 Neurosearch As Hidtil ukendte kaliumkanaler og gener, der koder for disse kaliumkanaler
CA2380807A1 (en) 1999-08-09 2001-04-12 University Of Utah Research Foundation Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same
AU7854900A (en) * 1999-10-08 2001-04-23 Vanderbilt University Method of screening for susceptibility to drug-induced cardiac arrhythmia
EP1176197A1 (de) * 2000-06-16 2002-01-30 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Transgenes Tiermodel für Herzarrythmien
US7034008B2 (en) * 2000-09-06 2006-04-25 The Johns Hopkins University Cardiac arrhythmia treatment methods
US8013133B2 (en) * 2003-04-25 2011-09-06 Medtronic, Inc. Genetic modification of targeted regions of the cardiac conduction system
US10917454B1 (en) 2019-08-01 2021-02-09 Rohde & Schwarz Gmbh & Co. Kg System and method for ATC voice quality assurance

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
CA1188246A (en) 1981-08-31 1985-06-04 Jerry L. Gregory Immobilized microbe recycle apparatus
US4868105A (en) 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
IE61148B1 (en) 1988-03-10 1994-10-05 Ici Plc Method of detecting nucleotide sequences
IL103059A0 (en) 1991-09-30 1993-02-21 Boehringer Ingelheim Int Conjugates for introducing nucleic acid into higher eucaryotic cells
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
US5599673A (en) * 1995-03-09 1997-02-04 University Of Utah Research Foundation Long QT syndrome genes

Also Published As

Publication number Publication date
EP0870041B1 (de) 2007-01-24
NZ330744A (en) 1999-02-25
DE69636870T2 (de) 2007-11-08
DE69636870D1 (de) 2007-03-15
WO1997023632A1 (en) 1997-07-03
EP0876491B1 (de) 2009-04-08
CA2240737C (en) 2009-09-29
EP0870041A2 (de) 1998-10-14
DE69637895D1 (de) 2009-05-20
EP0876491A1 (de) 1998-11-11
PT876491E (pt) 2009-07-14
DK0876491T3 (da) 2009-07-06
WO1997023598A2 (en) 1997-07-03
ATE427993T1 (de) 2009-04-15
JP2001519646A (ja) 2001-10-23
JP3449419B2 (ja) 2003-09-22
NZ330743A (en) 1999-07-29
EP0876491A4 (de) 2001-12-19
EP2085478A1 (de) 2009-08-05
ES2325820T3 (es) 2009-09-18
AU714041B2 (en) 1999-12-16
JP2001501445A (ja) 2001-02-06
WO1997023598A3 (en) 1997-09-12
AU1951297A (en) 1997-07-17
CA2240737A1 (en) 1997-07-03
AU1742897A (en) 1997-07-17
EP0870041A4 (de) 2002-01-23
AU714527B2 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
ATE352629T1 (de) Kvlqt1 - ein gen des long-qt-syndroms, welches für kvlqt1 kodiert und welches sich mit mink zusammensetzt, um iks-kaliumkanäle des herzens zu bilden
DE69510810D1 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
DK0991421T3 (da) Påvisning og modulering af IAP'er og NAIP i forbindelse med diagnose og behandling af proliferativ sygdom
AU7494701A (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
ATE312198T1 (de) Diagnose und behandlung von supravalvular aortic stenosis
US20030207303A1 (en) Method and kit for determining human geographic or population origin
NO872757D0 (no) Alkynylaminonukleotider og fremgangsmaate for fremstilling av disse.
NO904001D0 (no) Fremgangsmaate og anordning for amperometrisk diagnoseanalyse.
FR2703693B1 (fr) Procédé rapide de détermination d'une séquence d'ADN et application au séquençage et au diagnostic.
ATE328891T1 (de) Zusammensetzungen und verfahren zur behandlung und diagnose von immunstörungen
EE200100472A (et) Polüpeptiid, antikehad, lahustuv polüpeptiid, polü- või oligonukleotiid ja meetod diferentsiaalseltekspresseerunud DNA järjestuste spetsiifiliseks identifitseerimiseks
DE68928728D1 (de) Diagnose von retinoblastoma
Pande et al. Electroconvulsive therapy in delusional and non-delusional depressive disorder
Zeidler et al. Early arthritis and rheumatoid arthritis in Germany
Endreffy et al. HLA class II allele polymorphism in Hungarian patients with systemic lupus erythematosus
Hiew et al. Outcome in chronic inflammatory demyelinating polyneuropathy from a Malaysian centre over sixteen years
EP0870036A4 (de) Synthetische säugetier alpha-n-aectylglukosaminidase und dafür kodierende genetische sequenzen
Lavoie Psychosocial adjustment and personality functioning following postacute rehabilitation.
Wu et al. Analysis of tumor specific immunoglobulin gene rearrangement in peripheral blood B-cells of multiple myeloma patients by a PCR-SSCP method
Quinn Alzheimer conference highlights apolipoprotein E genotyping
Kelley Correction: Henry Clay and the Great State of Kentucky
Henderson Correction: Henry Clay and the Great State of Kentucky
Upshaw Urinary Methylmalonic Acid to Detect Vitamin B12 Deficiency-Reply
DePhilippis et al. Reducing Subject Attrition in Drug Abuse Studies: Identifying Attrition Risk Factors and Techniques to Improve Follow-up
DE69834831D1 (de) Gen, das im zusammenhang steht mit gemütskrankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties